Citations

Showing 10 of 108119 citations.

Brain responses to virtual reality visual motion stimulation are affected by neurotic personality traits in patients with persistent postural-perceptual dizziness
Riccelli, Roberta, Indovina, Iole , Passamonti, Luca , Lacquaniti, Francesco , Staab, Jeffrey P.

Mayo Clinic

Journal of Vestibular Research | March 5, 2019 | Volume: 28 | Issue: 5-6 | Pages: 369-378

10.3233/ves-190653 | PMID 30856138 Get It

Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2
Alvarado, Francisco , Yuchi, Zhiguang , Valdivia, Carmen R. , Hernández, Jonathan J. , Zhao, Yan-Ting , Henderlong, Dawn S., Booher, Talia R. , Marcou, Cherisse A. , Petegem, Filip Van , Ackerman, Michael J. , Valdivia, Héctor H. , Bos, J. Martijn , Henderlong, Dawn Shirley, Chen, Yan, Booher, Talia

Mayo Clinic

JCI Insight | March 5, 2019 | Volume: 4 | Issue: 7 | Pages: No page available

10.1172/jci.insight.126544 | PMID 30835254 Get It

Hypertrophic cardiomyopathy (HCM) is triggered mainly by mutations in genes encoding sarcomeric proteins, but a significant proportion of patients lack a genetic diagnosis. We identified a potentially novel mutation in ryanodine receptor 2, RyR2-P1124L, in a patient from a genotype-negative HCM cohort. The aim of this study was to determine whether RyR2-P1124L triggers functional and structural alterations in isolated RyR2 channels and whole hearts. We found that P1124L induces significant conformational changes in the SPRY2 domain of RyR2. Recombinant RyR2-P1124L channels displayed a cytosolic loss-of-function phenotype, which contrasted with a higher sensitivity to luminal [Ca 2+ ], indicating a luminal gain of function. Homozygous mice for RyR2-P1124L showed mild cardiac hypertrophy, similar to the human patient. This phenotype, evident at 1 year of age, was accompanied by an increase in the expression of calmodulin (CaM). P1124L mice also showed higher susceptibility to arrhythmia at 8 months of age, before the onset of hypertrophy. RyR2-P1124L has a distinct cytosolic loss-of-function and a luminal gain-of-function phenotype. This bifunctionally divergent behavior triggers arrhythmias and structural cardiac remodeling, and it involves overexpression of CaM as a potential hypertrophic mediator. This study is relevant to continue elucidating the possible causes of genotype-negative HCM and the role of RyR2 in cardiac hypertrophy.
Automated Droplet-Based Microfluidic Platform for Multiplexed Analysis of Biochemical Markers in Small Volumes
Cedillo‐Alcantar, Diana F. , Han, Yong Duk, García-Cordero, José L. , Revzin, Alexander , Choi, Jonghoon, Garcia-Cordero, Jose L , Revzin, Alexander , Choi, Jonghoon

Mayo Clinic

Analytical Chemistry | March 5, 2019 | Volume: 91 | Issue: 8 | Pages: 5133-5141

10.1021/acs.analchem.8b05689 | PMID 30834743 Get It

Lung US Surface Wave Elastography in Interstitial Lung Disease Staging
Zhou, Boran , Bartholmai, Brian J. , Kalra, Sanjay , Osborn, Thomas G. , Zhang, Xiaoming , Zhang, Xiaoming , Bartholmai, Brian J

Mayo Clinic

Radiology | March 5, 2019 | Volume: 291 | Issue: 2 | Pages: 479-484

10.1148/radiol.2019181729 | PMID 30835191 Get It

Adrenal Cortical Carcinoma Associated With Lynch Syndrome: A Case Report and Review of Literature
Kaur, Ravinder Jeet , Pichurin, Pavel N. , Hines, Jolaine M., Grebe, Stefan K., Singh, Ravinder J. , Bancos, Irina

Mayo Clinic

Journal of the Endocrine Society | March 5, 2019 | Volume: 3 | Issue: 4 | Pages: 784-790

10.1210/js.2019-00050 | PMID 30963136 Get It

Dynamic discriminant model for predicting respiratory distress at birth based on mass volume ratio in fetuses with congenital lung malformation
Eyerly‐Webb, Stephanie A. , Nicolas, Clara T., Watson, D. , Dion, Éric , Amin, Ruchi , Wagner, Amy J., Lampland, Andrea, Bendel‐Stenzel, Ellen , Macardle, C. A., Jorgenson, Alissa , Lillegard, Joseph B. , Feltis, Brad A. , Eyerly-Webb, S , Feltis, B , Watson, D., Kunisaki, Shaun Michael

Mayo Clinic

Ultrasound in Obstetrics & Gynecology | March 5, 2019 | Volume: 54 | Issue: 6 | Pages: 759-766

10.1002/uog.20255 | PMID 30834623 Get It

ABSTRACTObjectivesThe congenital lung malformation volume ratio (CVR) is a prenatal ultrasound measurement that parameterizes congenital lung malformation (CLM) size. The aims of this study were to use serial measurements to create estimated growth curves of fetal CVR for asymptomatic and symptomatic neonates with CLM and to investigate whether a discriminant prognostic model based on these measurements could predict accurately which fetuses with CLM will require invasive respiratory support at delivery and should therefore be delivered at a tertiary‐care facility.MethodsThis was a retrospective study of fetuses diagnosed prenatally with CLM at three tertiary‐care children's hospitals between 2009 and 2016. Those with two or more sonographic measurements of CVR were included. Serial fetal CVR measurements were used to create estimated growth curves for neonates with and those without respiratory symptoms at delivery, defined as requiring invasive respiratory support for the first 24 h after delivery. A discriminant model based on serial CVR measurements was used to calculate the dynamic probability of the need for invasive respiratory support. The performance of this model overall and in preterm and term neonates was compared with those using maximum CVR thresholds of 1.0 and 1.6.ResultsOf the 147 neonates meeting the inclusion criteria, 16 (10.9%) required postnatal invasive respiratory support. The estimated CVR growth curve models showed different growth trajectories for asymptomatic and symptomatic neonates, with significantly higher CVR in symptomatic neonates, and values peaking late in the second trimester at around 25 weeks' gestation in asymptomatic neonates. All prognostic methods had high accuracy for the prediction of the need for invasive respiratory support in term neonates, but the discriminant model had the best performance overall (area under the receiver–operating characteristics curve (AUC) = 0.88) and in the preterm population (AUC = 0.85).ConclusionsThe estimated CVR growth curves showed different growth patterns in asymptomatic and symptomatic neonates with CLM. The dynamic discriminant model performed well overall and particularly in neonates that were carried to term. Development of an externally validated clinical tool based on this analysis could be useful in determining the site of delivery for fetuses with CLM. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
Beneficial Effects of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Pas à Cause du BNP?
Pereira, Naveen L. , Desai, Viral , Jaffe, Allan S. , Desai, Viral K, Jaffe, Allan S.

Mayo Clinic

European Journal of Heart Failure | March 5, 2019 | Volume: 21 | Issue: 5 | Pages: 609-612

10.1002/ejhf.1451 | PMID 30834697 Get It

Retrosigmoid Approach for Resection of Medium-Sized Vestibular Schwannoma
Link, Michael J. , Driscoll, Colin L. W., Feng, Yening , Peris‐Celda, Maria , Graffeo, Christopher S.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 4, 2019 | Volume: 80 | Issue: S 03 | Pages: S284-S284

10.1055/s-0039-1677848 | PMID 31143591 Get It

Objectives This video was aimed to describe the relevant anatomy and key surgical steps of retrosigmoid approach for gross total resection of a medium-sized vestibular schwannoma (VS). Design The procedure is described in a surgical instructional video. Setting The surgery took place at a tertiary skull base referral center. Participant Patient is a 63-year-old woman who reported with nonserviceable hearing (Pure Tone Average 60 dB Hearing level, Word Recognition Score 45%), occasional tinnitus, and a VS in the left cerebellopontine angle (CPA), extending into internal auditory canal (IAC), measuring 1.7 cm parallel to the petrous temporal bone. Main Outcome Measures The VS was resected by retrosigmoid approach. Results The surgery results gross total resection of the VS with postoperative House–Brackmann grade 1 facial nerve function and no postoperative complications. Conclusion The retrosigmoid approach is a good strategy to remove VS involving the CPA and the IAC.The link to the video can be found at: https://youtu.be/B6K_UkrKitg.
From Herniation to Rehabilitation: A Young Woman With Rapidly Progressive Neurological Deficits
Sharma, Akanksha , Gonzalez‐Cuyar, Luis F. , Latimer, Caitlin S. , Longstreth, W. T., Tirschwell, David , Davis, Arielle , Foutz, Thomas J.

Mayo Clinic

The Neurohospitalist | March 4, 2019 | Volume: 9 | Issue: 4 | Pages: 215-221

10.1177/1941874419832437 | PMID 31534611 Get It

Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites
Nasir, Aqsa , Lehrke, Heidi D., Mounajjed, Taofic, Said, Samar M. , Zhang, Lizhi , Yasir, Saba , Shah, Sejal , Chandan, Vishal S. , Smyrk, Thomas C. , Moreira, Roger K. , Froemming, Jennifer M. Boland, Hernandez, Loren P. Herrera , Wu, Tsung‐Teh, Graham, Rondell P. , Said, Samar, Shah, Sejal S, Boland Froemming, Jennifer M, Herrera Hernandez, Loren P, Graham, Rondell P , Froemming, Jennifer Boland

Mayo Clinic

American Journal of Clinical Pathology | March 4, 2019 | Volume: 152 | Issue: 2 | Pages: 190-199

10.1093/ajcp/aqz032 | PMID 31107526 Get It

ABSTRACT Objectives Albumin messenger RNA (mRNA) expression is a marker of hepatocellular differentiation. Most published data are from review of tissue microarrays, and albumin in situ hybridization (ISH) expression across several tumor types is incompletely characterized. Methods Sections from 221 tumors were evaluated for albumin mRNA. Immunohistochemistry was used to confirm diagnoses. Albumin ISH was performed according to manufacturer-provided instructions. Fifty-nine cases were evaluated with both commercial ISH assays. Results Albumin mRNA was detected in all hepatocellular carcinomas (HCCs) and 81% of intrahepatic cholangiocarcinomas. Lung (20%), gallbladder (39%), hepatoid pancreatic (n = 1 of 1) adenocarcinoma, breast invasive ductal carcinoma (18%), yolk sac tumor (25%), and acinar cell carcinoma (29%) showed expression. Both assays were concordant in 93% of cases. Conclusions Albumin ISH was expressed in all HCCs studied. It was also positive in intrahepatic cholangiocarcinoma and patchy positive in gallbladder adenocarcinoma and a subset of other neoplasms, which can be a potential pitfall.